Comparative evaluation of skin wound healing depending on the type of medication correction of experimental hypogonadism in male rats

Introduction. The hypothalamic-pituitary-gonadal system plays a key role in the adaptive processes of the body. Severe traumatic injuries cause a complex of endocrine disorders, including a decrease in androgens. Given the powerful anabolic potential of androgens, timely correction of their reduction contributes to optimizing the clinical status of the patient and improving reparative processes.
Aim. To evaluate the effect of various therapeutic regimens using testosterone and gonadotropin preparations on skin wound healing during the granulation tissue formation stage.
Materials and methods. An experimental study was conducted on skin wound healing in rats at the granulation tissue formation stage under pre-modeled hypogonadotropic hypogonadism conditions. A total of 62 male Sprague Dawley rats were included in the final analysis, divided into groups receiving testosterone in physiological and supraphysiological doses, dihydrotestosterone, and chorionic gonadotropin.
Results. Physiological doses of testosterone had an adverse effect on regeneration due to tissue edema, vascular thrombosis, and prolonged inflammation phase (with an interphase increase in mast cell population density by 21.5 times), whereas dihydrotestosterone and supraphysiological concentrations of testosterone contributed to accelerated maturation of granulation tissue by day 14 and a reduction in mast cell population density by 89.5% and 13.8%, respectively. Chorionic gonadotropin demonstrated a positive effect on granulation tissue maturation and angioprotection while simultaneously prolonging the inflammatory phase, comparable to the hypogonadal rat group without therapy (with a 2.7-fold increase in mast cell population and a concurrent 24.7% increase in mast cell degranulation index compared to day 7).
Conclusion. The results of this study can be considered in the development of methods for stimulating reparative processes, as under hypogonadotropic hypogonadism conditions, they allow for the identification of more effective approaches depending on the initial state of the wound defect, testosterone preparation, and its dosage.

1. Okhunov AO, Pulatov UI, Okhunova DA. Clinical and laboratory characteristics of the wound process soft tissue. Vestnik Nauki i Obrazovaniya. 2018;(9):104–110. (In Russ.) Available at: https://elibrary.ru/xvqsuh.

2. Salukhov VV, Aysaeva SV. Functional hypogonadism in men: key causes and neuroendocrine mechanisms of its development. Meditsinskiy Sovet. 2024;18(6):112–123. (In Russ.) https://doi.org/10.21518/ms2024-210.

3. Hackney AC. Hypogonadism in exercising males: Dysfunction or adaptiveregulatory adjustment? Front Endocrinol. 2020;11:11. https://doi.org/10.3389/fendo.2020.00011.

4. Koubassov RV. Hormonal Changes in Response to Extreme Environment Factors. Annals of Russian Academy of Medical Sciences. 2014;69(9-10): 102–109. (In Russ.) https://doi.org/10.15690/vramn.v69i9-10.1138.

5. Geddes RI, Kapoor A, Hayashi K, Rauh R, Wehber M, Bongers Q et al. Hypogonadism induced by surgical stress and brain trauma is reversed by human chorionic gonadotropin in male rats: A potential therapy for surgical and TBI-induced hypogonadism? Endocrinol Diabetes Metab. 2021;4(3):e00239. https://doi.org/10.1002/edm2.239.

6. Salukhov VV, Minakov AA, Ajsaeva SV. Condition of hypothalamic-pituitarygonadal system in military personnel. Literature review. Medical Bulletin of the Ministry of Internal Affairs. 2024;131(4):41–48. (In Russ.) https://doi.org/10.52341/20738080_2024_131_4_41.

7. Байрамов АА, Никитина ИЛ, Юхлина ЮН, Гринева ЕН, Шабанов ПД, Галагудза ММ и др. Способ моделирования мужского гипогонадотропного гипогонадизма. Патент RU 2749477 C1, 11.06.2021. Режим доступа: https://elibrary.ru/gaydbo.

8. Shekunova EV, Kovaleva MA, Makarova MN, Makarov VG. Dose Selection in Preclinical Studies: Cross-Species Dose Conversion. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation. 2020;10(1):19–28. (In Russ.) https://doi.org/10.30895/1991-2919-2020-10-1-19-28.

9. Birina VV, Odintsova IA, Rusakova SE. Comparative characteristic of proliferation of fibroblasts and functional activity of mast cells in regeneration histogenesis after a gunshot wound. Russian Military Medical Academy Reports. 2020;39(1):42–47. (In Russ.) Available at: https://elibrary.ru/xifnvg.

10. Alexeeva NT, Glukhov AA. The role of mast cells in wound healing. Journal of Experimental and Clinical Surgery. 2011;4(4):864–870. (In Russ.) Available at: https://elibrary.ru/ovyqjf.

11. Alexeeva NT, Klochkova SV, Nikitiuk DB. Morphological characteristics of mast cells in the regeneration of skin. Orenburg Medical Bulletin. 2016;4(3-1):13–16. (In Russ.) Available at: https://elibrary.ru/wmnvyr.

12. Ashworth JJ, Ashcroft GS. The hormonal regulation of cutaneous wound healing. Clin Dermatol. 2007;25(1):56–62. https://doi.org/10.1016/j.clindermatol.2006.09.012.

13. Arazi H, Mohammadjafari H, Asadi A. Use of anabolic androgenic steroids produces greater oxidative stress responses to resistance exercise in strengthtrained men. Toxicol Rep. 2017;4:282–286. https://doi.org/10.1016/j.toxrep.2017.05.005.

14. Karavitakis M, Komninos C, Simaioforidis V, Kontos S, Lefakis G, Politis V et al. The relationship between androgens, regulators of collagen metabolism, and Peyronie’s disease: a case control study. J Sex Med. 2010;7(12):4011–4017. https://doi.org/10.1111/j.1743-6109.2010.01915.x.

15. Bhasin S, Woodhouse L, Casaburi R, Singh AB, Bhasin D, Berman N et al. Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab. 2001;281(6):E1172–E1181. https://doi.org/10.1152/ajpendo.2001.281.6.E1172.

16. Morgentaler A, Traish AM. Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. Eur Urol. 2009;55(2):310–320. https://doi.org/10.1016/j.eururo.2008.09.024.

17. Nackeeran S, Kohn T, Gonzalez D, White J, Ory J, Ramasamy R. The Effect of Route of Testosterone on Changes in Hematocrit: A Systematic Review and Bayesian Network Meta-Analysis of Randomized Trials. J Urol. 2022;207(1):44–51. https://doi.org/10.1097/JU.0000000000002188.

18. Estrada M, Espinosa A, Müller M, Jaimovich E. Testosterone stimulates intracellular calcium release and mitogen-activated protein kinases via a G protein-coupled receptor in skeletal muscle cells. Endocrinology. 2003;144(8):3586–3597. https://doi.org/10.1210/en.2002-0164.

19. Estrada M, Liberona JL, Miranda M, Jaimovich E. Aldosterone- and testosterone--mediated intracellular calcium response in skeletal muscle cell cultures. Am J Physiol Endocrinol Metab. 2000;279(1):E132–E139. https://doi.org/10.1152/ajpendo.2000.279.1.E132.

20. Hamdi M, Mutungi G. Dihydrotestosterone activates the MAPK pathway and modulates maximum isometric force through the EGF receptor in isolated intact mouse skeletal muscle fibres. J Physiol. 2010;588(Pt 3):511–525. https://doi.org/10.1113/jphysiol.2009.182162.

21. Corti M, Lorenzetti S, Ubaldi A, Zilli R, Marcoccia D. Endocrine Disruptors and Prostate Cancer. Int J Mol Sci. 2022;23(3):1216. https://doi.org/10.3390/ijms23031216.

22. Zarif JC, Miranti CK. The importance of non-nuclear AR signaling in prostate cancer progression and therapeutic resistance. Cell Signal. 2016;28(5):348–356. https://doi.org/10.1016/j.cellsig.2016.01.013.

23. Cousins FL, Kirkwood PM, Murray AA, Collins F, Gibson DA, Saunders PT. Androgens regulate scarless repair of the endometrial “wound” in a mouse model of menstruation. FASEB J. 2016;30(8):2802–2811. https://doi.org/10.1096/fj.201600078R.

24. Hemat RAS. Principles of Orthomolecularism. Urotext; 2004. 488 p. Available at: https://books.google.ru/books?id=ED_xI-CEzFYC&printsec=frontcover#v=onepage&q&f=false.

25. Détriché G, Gendron N, Philippe A, Gruest M, Billoir P, Rossi E et al. Gonadotropins as novel active partners in vascular diseases: Insight from angiogenic properties and thrombotic potential of endothelial colony-forming cells. J Thromb Haemost. 2022;20(1):230–237. https://doi.org/10.1111/jth.15549.